BACKGROUND: A previous analysis of children infected with human immunodeficiency virus (HIV) in the Women and Infants Transmission Study showed a strong correlation between low activated CD8(+) T lymphocytes in the first 2 months of life and good immunological prognosis. We sought to extend these observations to neurodevelopmental prognosis. METHODS: Ninety-eight HIV-infected children born before 1994 with flow cytometric data from the first 2 months of life and adequate neurodevelopmental testing through age 30 months were studied. Children were divided into those with low (<or=5% CD8(+)HLA-DR(+) cells or <or=25% CD8(+)CD38(+) cells) or high (>5% CD8(+)HLA-DR(+) cells or >25% CD8(+)CD38(+) cells) immune activation at 1 and/or 2 months of age. Analysis was performed using survival analysis, Cox's proportional hazard regression, and longitudinal regression models. RESULTS: Absence of immune activation, measured as <or=5% CD8(+)HLA-DR(+) cells, was strongly associated with better performance on the psychomotor developmental index of the Bayley scales of infant development through the third year of life. This association persisted after adjustment for CD4 cell count, viral load, and progression to acquired immunodeficiency syndrome (P= .005). An association with the mental development index was also present (P= .048). Significant association between neurodevelopmental outcomes and <or=25% CD8(+)CD38(+) cells was not seen. CONCLUSIONS: In this prospective cohort study of HIV-infected children, there was a significant favorable association of low immune activation in peripheral T cells at age 1 or 2 months, measured by a low percentage of CD8(+)HLA-DR(+) cells, with subsequent psychomotor and mental development. This association was independent of other indices of severity and progression of HIV infection.
BACKGROUND: A previous analysis of children infected with human immunodeficiency virus (HIV) in the Women and Infants Transmission Study showed a strong correlation between low activated CD8(+) T lymphocytes in the first 2 months of life and good immunological prognosis. We sought to extend these observations to neurodevelopmental prognosis. METHODS: Ninety-eight HIV-infectedchildren born before 1994 with flow cytometric data from the first 2 months of life and adequate neurodevelopmental testing through age 30 months were studied. Children were divided into those with low (<or=5% CD8(+)HLA-DR(+) cells or <or=25% CD8(+)CD38(+) cells) or high (>5% CD8(+)HLA-DR(+) cells or >25% CD8(+)CD38(+) cells) immune activation at 1 and/or 2 months of age. Analysis was performed using survival analysis, Cox's proportional hazard regression, and longitudinal regression models. RESULTS: Absence of immune activation, measured as <or=5% CD8(+)HLA-DR(+) cells, was strongly associated with better performance on the psychomotor developmental index of the Bayley scales of infant development through the third year of life. This association persisted after adjustment for CD4 cell count, viral load, and progression to acquired immunodeficiency syndrome (P= .005). An association with the mental development index was also present (P= .048). Significant association between neurodevelopmental outcomes and <or=25% CD8(+)CD38(+) cells was not seen. CONCLUSIONS: In this prospective cohort study of HIV-infectedchildren, there was a significant favorable association of low immune activation in peripheral T cells at age 1 or 2 months, measured by a low percentage of CD8(+)HLA-DR(+) cells, with subsequent psychomotor and mental development. This association was independent of other indices of severity and progression of HIV infection.
Authors: Thomas D Marcotte; Reena Deutsch; J Allen McCutchan; David J Moore; Scott Letendre; Ronald J Ellis; Mark R Wallace; Robert K Heaton; Igor Grant Journal: Arch Neurol Date: 2003-10
Authors: Gayle G Sherman; Lesley E Scott; Jacqueline S Galpin; Louise Kuhn; Caroline T Tiemessen; Karen Simmank; Stephen Meddows-Taylor; Tamara M Meyers Journal: Pediatr Res Date: 2002-06 Impact factor: 3.756
Authors: C Chase; J Ware; J Hittelman; I Blasini; R Smith; A Llorente; E Anisfeld; C Diaz; M G Fowler; J Moye; L I Kaligh Journal: Pediatrics Date: 2000-08 Impact factor: 7.124
Authors: R Smith; K Malee; M Charurat; L Magder; C Mellins; C Macmillan; J Hittleman; T Lasky; A Llorente; J Moye Journal: Pediatr Infect Dis J Date: 2000-09 Impact factor: 2.129
Authors: C Macmillan; L S Magder; P Brouwers; C Chase; J Hittelman; T Lasky; K Malee; C A Mellins; J Velez-Borras Journal: Neurology Date: 2001-10-23 Impact factor: 9.910
Authors: Silvia Sánchez-Ramón; José Ma Bellón; Salvador Resino; Carmen Cantó-Nogués; Dolores Gurbindo; José-Tomás Ramos; Ma Angeles Muñoz-Fernández Journal: Pediatrics Date: 2003-02 Impact factor: 7.124
Authors: William T Shearer; Howard M Rosenblatt; Rebecca S Gelman; Rebecca Oyomopito; Susan Plaeger; E Richard Stiehm; Diane W Wara; Steven D Douglas; Katherine Luzuriaga; Elizabeth J McFarland; Ram Yogev; Mobeen H Rathore; Wende Levy; Bobbie L Graham; Stephen A Spector Journal: J Allergy Clin Immunol Date: 2003-11 Impact factor: 10.793
Authors: Cynthia Fair; Lori Wiener; Sima Zadeh; Jamie Albright; Claude Ann Mellins; Michael Mancilla; Vicki Tepper; Connie Trexler; Julia Purdy; Janet Osherow; Susan Lovelace; Suad Kapetanovic Journal: Matern Child Health J Date: 2013-07
Authors: Kathleen M Malee; Katherine Tassiopoulos; Yanling Huo; George Siberry; Paige L Williams; Rohan Hazra; Renee A Smith; Susannah M Allison; Patricia A Garvie; Betsy Kammerer; Suad Kapetanovic; Sharon Nichols; Russell Van Dyke; George R Seage; Claude A Mellins Journal: AIDS Care Date: 2011-12
Authors: Suad Kapetanovic; Lisa Aaron; Grace Montepiedra; Patricia A Sirois; James M Oleske; Kathleen Malee; Deborah A Pearson; Sharon L Nichols; Patricia A Garvie; John Farley; Molly L Nozyce; Mark Mintz; Paige L Williams Journal: AIDS Patient Care STDS Date: 2009-11 Impact factor: 5.078
Authors: Ravi Tandon; Maria T M Giret; Devi Sengupta; Vanessa A York; Andrew A Wiznia; Michael G Rosenberg; Esper G Kallas; Lishomwa C Ndhlovu; Douglas F Nixon Journal: PLoS One Date: 2012-09-24 Impact factor: 3.240
Authors: Caroline C Dias; Victoria Ayala; Fartun A Aliduux; Sayeda A Basith; Albulena Sejdiu; Miles M Nakaska; Sabiha Akter; Keerthika Mathialagan; Pradipta Majumder Journal: Cureus Date: 2021-06-16